Does Prehabilitation Improve Outcome in Coloncancer Surgery?

NCT ID: NCT04199208

Last Updated: 2020-04-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-01

Study Completion Date

2028-01-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to find out if complications after surgery for large bowel (colon) cancer can be reduced or avoided in the most frail and elderly by letting them go through an exercise- and diet regime prior to the surgical procedure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients with colon cancer who are intended for curative surgery without neoadjuvant chemotherapy who are \>=60 years old will be screened with an ergospirometry. The ones that have a ventilate anaerobic threshold (VAT) of less than 11 mg/ml/kg will be included in the study as they are considered extra frail and have a previously proven high risk for complications. These patients will be randomized to standard care or an intervention of prehabilitation consisting of immunonutrition (protein supplement, multivitamin supplement, Selene etc) and an exercise regimen with 4x1 hours per week of cycling on an ergometer. The exercise regimen will be performed in a group of patients and will be led by a physical therapist to ensure compliance. The resistance of the ergometer will be standardized according to the patient's VAT.

The primary outcome measures will be number of and severity of postoperative complications. Secondary outcome measures include quality of life during prehabilitation with repeated measurements during 5 years after surgery, disease-free survival and overall survival.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgery--Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized two-armed clinical trial
Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Care Arm

Standard perioperative care is given.

Group Type ACTIVE_COMPARATOR

Standard Care Arm

Intervention Type OTHER

Standard care as per the daily routines of the Hospital at which the study takes place

Interventional Arm

Intervention of prehabilitation and immunonutrition is given prior to surgery

Group Type EXPERIMENTAL

Prehabilitation and Immunonutrition

Intervention Type OTHER

See study synopsis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prehabilitation and Immunonutrition

See study synopsis

Intervention Type OTHER

Standard Care Arm

Standard care as per the daily routines of the Hospital at which the study takes place

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 60 years of older
* Colon cancer diagnosis (macroscopic, microscopic or x-ray diagnosed)
* Ventilatory Anaerobic Threshold \<11mg/ml/kg
* Planned open or laparoscopic colectomy due to colon cancer

Exclusion Criteria

* Lower extremity amputee
* Disease requiring radio- and/or chemotherapy prior to surgery/palliative disease
* Distal metastases (Locoregional lymph nodes are OK)
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Region Skane

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stefan Öberg, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Region Skåne/Lund University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Stefan Öberg, MD, PhD

Role: CONTACT

+46424061000

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PRIO01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mechanistic Prehabilitation
NCT01919541 WITHDRAWN NA
Prehabilitation for Gastrectomy
NCT04223401 ACTIVE_NOT_RECRUITING NA